VoxCell BioInnovation to Be Featured on All Access with Andy Garcia

Victoria, February 2025—VoxCell BioInnovation is thrilled to announce that it will be featured in an upcoming segment of All Access with Host Andy Garcia, a nationally aired educational program that showcases breakthrough innovations shaping the future.

The segment is scheduled to stream later this summer, stay tuned for release details and updates.

Inside the Segment: The Future of Medicine

This segment will spotlight how our 3D bioprinting technology, developing our vascularized tissue models, is transforming the landscape of drug development by offering:

• Predictive, human-like tissue models for more accurate drug testing

• A pathway to personalized medicine, tailored to each individual

• A more ethical and effective alternative to animal testing

At VoxCell, we are not asking the pharmaceutical industry to change what they do—we are providing the tools to do it better.

Dr. Karolina Valente, CEO of VoxCell BioInnovation

Our inclusion in All Access reflects the growing recognition of the urgent need for innovation in preclinical testing. By replicating human tissues, complete with vasculature, our bioprinted models provide researchers with unprecedented insight into how drugs behave in the human body, thereby reducing reliance on outdated models and animal testing.

With our advanced tissue models, a new dimension in drug development can be unlocked, accelerating the preclinical pathway with models that truly mimic human biology.

Dr. Karolina Valente, CEO of VoxCell BioInnovation

This segment takes viewers on a journey into the future of medicine, one where patients benefit from faster, safer, and more personalized treatments. VoxCell’s mission is to help make this future a reality by equipping the pharmaceutical industry with the tools it needs to advance human health.

About All Access with Andy Garcia

Airing on public television stations across the U.S., All Access is an educational TV program offering in-depth perspectives on emerging technologies, healthcare advancements, and transformative companies that are shaping the world of tomorrow.

Read the Full Press Release

The All Access segment featuring VoxCell is set to stream later this summer. Follow us on LinkedIn and subscribe to our newsletter to be the first to know when it airs and how to watch it.

About VoxCell BioInnovation

VoxCell BioInnovation is a leading provider of next-generation in vitro models, powered by our 3D bioprinted, vascularized tissue technology. Our ready-to-perfuse models closely replicate human biology with in vivo–like microvascular networks, enabling nutrient and oxygen delivery, systemic drug distribution, and more predictive therapeutic responses. VoxCell’s end-to-end solution offers researchers and pharmaceutical companies a scalable, ethical alternative to animal testing. Our mission is to reduce reliance on animal models, accelerate preclinical development, and advance more effective therapies for patients.

Want to learn more or collaborate?

Visit our website, connect with us on LinkedIn, or email us at hello@voxcellbio.com.